Dark

CAPS
Capstone Holding Corp. Common Stock
stock NASDAQ

At Close

May 16, 2025 3:59:30 PM EDT

2.51USD+51.205%(+0.85)21,573,238

2.44Bid 2.46Ask 0.02Spread

Pre-market

May 16, 2025 9:29:54 AM EDT

2.76USD+66.265%(+1.10)9,426,121

After-hours

May 16, 2025 4:58:30 PM EDT

2.40USD-4.382%(-0.11)156,230

OverviewHistoricalExchangesShortsTrends

open chart

Market Cap

13.03M

Headquarters

Tempe, Arizona, USA

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Last Split

Sep 10, 20191for1,000reverse

CAPS Stats

Avg. Vol. 10 Day

76,735

Avg. Vol. 30 Day

58,487

Market Cap

13,027,530

Shares Out.

5,190,251

On/Off Exchange

48%/52%

6 Month Beta

1.47

1 Year Beta

1.53

2 Year Beta

1.52

3 Year Beta

1.37

52 Week Low

1.58

52 Week High

16.18

SMA50

2.29

SMA200

14.61

1 Week

+43.43%

1 Month

+14.61%

3 Month

+0.40%

6 Month

-33.60%

1 Year

-45.73%

2 Year

-68.63%

5 Year

-84.31%

Profile

capstone therapeutics (otcqb: caps) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. capstone holds an fda orphan drug designation for its lead molecule, aem-28, for homozygous familial hypercholesterolemia (hofh) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.

CAPS Stock Summary

Capstone Holding Corp. Common Stock (NASDAQ:CAPS) stock price today is $2.51, and today's volume is 21,573,238. CAPS is up 51.205% today. The 30 day average volume is 58,487. CAPS market cap is 13.03M with 5,190,251 shares outstanding.

.dark-mode .TkSGTg{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .TkSGTg{ color: #333333; background-color: white; border: 2px solid #333333; }CAPSCapstone Holding Corp. Common Stockstock NASDAQ

CAPS Stock Summary

CAPS
Capstone Holding Corp. Common Stock
stock NASDAQ